Kyle Rose
Stock Analyst at Canaccord Genuity
(2.69)
# 2,046
Out of 4,944 analysts
114
Total ratings
53.26%
Success rate
13.73%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNN Smith & Nephew | Maintains: Hold | $27 | $36.65 | -26.33% | 6 | Feb 26, 2025 | |
| PODD Insulet | Maintains: Buy | $304 → $324 | $310.26 | +4.43% | 16 | Feb 21, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $377.00 | +15.38% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $62.33 | +13.91% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $30.02 | +136.55% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $14.50 | +51.72% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $2.39 | +318.41% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $15.88 | +38.54% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $81.19 | +84.75% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $9.52 | +2,736.13% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $15.76 | +71.37% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.61 | +831.68% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $14.07 | +6.61% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $180.70 | -32.48% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $4.14 | -3.38% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.38 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $102.98 | +21.38% | 7 | Feb 8, 2022 |
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $36.65
Upside: -26.33%
Insulet
Feb 21, 2025
Maintains: Buy
Price Target: $304 → $324
Current: $310.26
Upside: +4.43%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $377.00
Upside: +15.38%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $62.33
Upside: +13.91%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $30.02
Upside: +136.55%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $14.50
Upside: +51.72%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $2.39
Upside: +318.41%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $15.88
Upside: +38.54%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $81.19
Upside: +84.75%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $9.52
Upside: +2,736.13%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $15.76
Upside: +71.37%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $1.61
Upside: +831.68%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $14.07
Upside: +6.61%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $180.70
Upside: -32.48%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $4.14
Upside: -3.38%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $7.38
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $102.98
Upside: +21.38%